查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555691

心血管保健品市場，按補充劑類型、形式、分佈、人口統計、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Cardiovascular Health Supplements Market, By Supplement Type, By Form, By Distribution, By Demographics, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，心血管保健品市場規模為112.3423億美元，2024年至2032年複合年成長率為8.98%。

心血管保健品市場-市場動態

全球對心血管疾病的認知和盛行率的提高推動了心血管保健品市場的成長

全球對心血管疾病的認知不斷增強，加上其盛行率不斷上升，大大增加了對心血管保健品的需求。根據世界衛生組織 (WHO) 的數據，心血管疾病是全球主要死亡原因，每年約導致 1,790 萬人死亡。這項令人震驚的統計數據促使公共和私人衛生組織推廣預防措施，包括使用 omega-3 脂肪酸和 CoQ10 等補充劑。例如，美國心臟協會建議將特定的膳食補充劑作為心臟健康生活方式的一部分，反映了預防性保健的更廣泛趨勢。此外，疾病預防控制中心的一份報告強調，美國近一半的成年人患有某種形式的心血管疾病，這進一步強調了迫切需要採取干涉措施（包括補充劑）來管理和減少與心臟病相關的危險因子。

心血管保健品市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.98% 左右的複合年成長率成長

根據補充劑類型細分，預計 Omega-3 脂肪酸將在 2023 年顯示最大的市場佔有率

按形態細分，膠囊為2023年主導類型

從分銷細分來看，2023年線上零售為主導類型

按地區分類，北美是 2023 年的主要收入來源

心血管保健品市場-細分分析：

全球心血管保健品市場根據補充劑類型、形式、分佈、人口統計和地區進行細分。

根據補充劑類型，市場分為五類：Omega-3 脂肪酸、輔酶 Q10、纖維補充劑、植物固醇和抗氧化劑。 Omega-3 脂肪酸因其支持心臟健康的有力證據而引領心血管保健補充劑市場，其次是輔酶 Q10 和植物固醇，因為它們越來越受歡迎。纖維補充劑和抗氧化劑的優先順序較低，但仍然必不可少。

市場依劑型分為五類：藥片、膠囊、粉末、液體補充劑和軟糖。膠囊和片劑因其便利性和穩定性而在心血管保健品市場佔據主導地位，其次是劑量靈活的粉末。液體補充劑越來越受歡迎，而軟糖雖然不太受重視，但吸引了特定消費者的偏好。

心血管保健品市場-地理洞察

北美在市場上佔據主導地位，這主要是由於高意識水平、先進的醫療保健系統以及對預防性醫療保健的高度重視。美國尤其在該地區處於領先地位，有很大一部分人口定期使用心臟保健補充劑。歐洲緊隨其後，由於人口老化和心血管疾病發生率上升，德國和英國等國家的採用率不斷提高。在亞太地區，受可支配收入增加、城市化和健康意識增強的推動，市場正在迅速擴張，特別是在中國、日本和印度等國家。然而，拉丁美洲和非洲等地區的市場滲透率仍然較低，這些地區的主要挑戰是認知和獲取補充劑的機會有限。儘管如此，隨著意識和經濟狀況的改善，這些地區提供了尚未開發的市場成長機會。

心血管保健品市場-競爭格局：

主要行業參與者包括雅培實驗室、安麗、拜耳公司和康寶萊營養品等知名公司，它們利用強大的品牌知名度、廣泛的分銷網路和強大的研發能力。這些公司專注於產品創新，通常會結合 omega-3 脂肪酸、輔酶 Q10 和植物固醇等有科學依據的成分，以使其產品脫穎而出。此外，許多參與者正在擴大其產品組合，包括針對個人健康需求量身定做的個人化補充劑，從而吸引更廣泛的消費者群體。該市場還面臨來自小型專業公司的激烈競爭，這些公司以獨特的配方和天然成分迎合利基市場。隨著公司尋求增強其市場影響力和地理覆蓋範圍，策略合作夥伴關係、合併和收購很常見。儘管競爭激烈，但對心臟保健補充劑不斷成長的需求繼續為新進者和現有參與者提供充足的機會。

最新進展：

2023 年 6 月，Healthycell 推出了心臟和血管健康產品，這是一種超可吸收的凝膠補充劑，旨在支持正常的膽固醇、三酸甘油酯和血壓水平。它結合了植物成分和維生素，在單一凝膠包中提供簡單、無藥物的心臟健康解決方案。

2023 年 7 月，英國 Dr. Vegan 推出了兩款新補充劑：含有植物固醇的用於心血管支持的 HeartPro，以及含有益生菌的用於女性陰道健康的 pH Hero。此次推出擴大了品牌的植物性產品範圍，以滿足消費者對天然、合乎道德的補充劑日益成長的需求。

目錄

第1章：心血管保健品市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 心血管保健品市場摘要（按補充劑類型）
    • 心血管保健品市場摘要（按形式）
    • 心血管保健品市場片段（依分佈）
    • 按人口統計的心血管保健品市場片段
    • 按國家/地區分類的心血管保健品市場摘要
    • 按地區分類的心血管保健品市場片段
  • 競爭洞察

第 3 章：心血管保健品主要市場趨勢

  • 心血管保健品市場促進因素
    • 市場促進因素的影響分析
  • 心血管保健品市場限制
    • 市場限制影響分析
  • 心血管保健品市場機會
  • 心血管保健品市場未來趨勢

第 4 章：心血管保健品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：心血管保健品市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：心血管保健品市場格局

  • 2023 年心血管保健品市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：心血管保健品市場 - 依補充劑類型

  • 概述
    • 按補充劑類型分類的細分市場佔有率分析
    • Omega-3 脂肪酸
    • 輔酶Q10
    • 纖維補充劑
    • 植物固醇
    • 抗氧化劑

第 8 章：心血管保健品市場 - 按形式

  • 概述
    • 細分市場佔有率分析（按形式）
    • 平板電腦
    • 膠囊
    • 粉末
    • 液體補充劑
    • 軟糖

第 9 章：心血管保健品市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 網路零售
    • 保健食品店
    • 藥局
    • 超市
    • 直銷

第 10 章：心血管保健品市場 - 按人口統計

  • 概述
    • 按人口統計資料進行細分市場佔有率分析
    • 成年人
    • 老年
    • 孩子們
    • 特定健康狀況

第 11 章：心血管保健品市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美心血管保健品主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按補充劑類型）
    • 北美市場規模及預測（按形式）
    • 北美市場規模和預測（按分佈）
    • 北美市場規模和預測（按人口統計）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲心血管保健品主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按補充劑類型）
    • 歐洲市場規模與預測（按形式）
    • 歐洲市場規模與預測（按分佈）
    • 歐洲市場規模和預測（按人口統計）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區心血管保健品主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按補充劑類型）
    • 亞太地區市場規模與預測（按形式）
    • 亞太地區市場規模與預測（按分佈）
    • 亞太地區市場規模與預測（依人口統計）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲心血管保健品主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按補充劑類型）
    • 拉丁美洲市場規模與預測（按形式）
    • 拉丁美洲市場規模與預測（按分佈）
    • 拉丁美洲市場規模與預測（按人口統計）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲心血管保健品主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按補充類型）
    • 中東和非洲市場規模及預測（按形式）
    • 中東和非洲市場規模及預測（按分佈）
    • 中東和非洲市場規模及預測（按人口統計）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 心血管保健品產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer Inc.
    • Nature's Bounty Co.
    • Herbalife Nutrition Ltd.
    • Amgen Inc.
    • GNC Holdings, Inc.
    • BASF SE
    • Abbott Laboratories
    • GlaxoSmithKline plc
    • DSM Nutritional Products
    • The Nature's Way Products, LLC
    • Nutrilite (Amway)
    • MegaFood (FoodState)
    • Now Foods
    • Solgar Inc.
    • Blackmores Limited
    • Thrive Market
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3701

REPORT HIGHLIGHT

Cardiovascular Health Supplements Market size was valued at USD 11,234.23 Million in 2023, expanding at a CAGR of 8.98% from 2024 to 2032.

The Cardiovascular Health Supplements Market focuses on products aimed at supporting heart health through various nutritional formulations, including omega-3 fatty acids, CoQ10, and plant sterols. Rising awareness about cardiovascular diseases, coupled with increasing incidences of heart-related conditions due to lifestyle changes, has fueled demand for these supplements. Growing consumer inclination towards preventive healthcare and the ageing global population further intensify this trend. However, the market faces challenges like stringent regulatory requirements and skepticism regarding the efficacy of these supplements. Opportunities lie in developing innovative products, such as personalized supplements, and expanding distribution channels.

Cardiovascular Health Supplements Market- Market Dynamics

Increasing Global Awareness and Prevalence of Cardiovascular Diseases Propel Cardiovascular Health Supplements Market Growth

The growing global awareness of cardiovascular diseases, coupled with their rising prevalence, has significantly boosted the demand for cardiovascular health supplements. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. This alarming statistic has driven both public and private health organizations to promote preventive measures, including the use of supplements like omega-3 fatty acids and CoQ10. For instance, the American Heart Association has recommended the inclusion of specific dietary supplements as part of a heart-healthy lifestyle, reflecting the broader trend toward preventive healthcare. Furthermore, a report from the CDC highlighted that nearly half of all adults in the United States have some form of cardiovascular disease, further underlining the critical need for interventions, including supplementation, to manage and reduce risk factors associated with heart conditions.

Cardiovascular Health Supplements Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.98% over the forecast period (2024-2032)

Based on Supplement Type segmentation, Omega-3 Fatty Acids was predicted to show maximum market share in the year 2023

Based on Form segmentation, Capsules was the leading type in 2023

Based on distribution segmentation, Online Retail was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cardiovascular Health Supplements Market- Segmentation Analysis:

The Global Cardiovascular Health Supplements Market is segmented based on Supplement Type, Form, Distribution, Demographics, and Region.

The market is divided into five categories based on Supplement Type: Omega-3 Fatty Acids, Coenzyme Q10, Fiber Supplements, Plant Sterols, and Antioxidants. Omega-3 fatty acids lead the cardiovascular health supplement market due to their strong evidence in supporting heart health, followed by Coenzyme Q10 and Plant Sterols for their growing popularity. Fiber Supplements and Antioxidants rank lower in priority, yet remain essential.

The market is divided into five categories based on Form: Tablets, Capsules, Powders, Liquid Supplements, and Gummies. Capsules and Tablets dominate the Cardiovascular Health Supplements market due to their convenience and stability, followed by Powders for flexible dosing. Liquid Supplements are gaining traction, while Gummies, though less prioritized, appeal to specific consumer preferences.

Cardiovascular Health Supplements Market- Geographical Insights

North America dominates the market, largely due to high awareness levels, advanced healthcare systems, and a strong focus on preventive healthcare. The U.S., in particular, leads the region, with a substantial portion of the population regularly using heart health supplements. Europe follows closely, with countries like Germany and the UK witnessing growing adoption driven by an ageing population and increasing incidences of cardiovascular diseases. In the Asia-Pacific region, the market is expanding rapidly, fueled by rising disposable incomes, urbanization, and growing health consciousness, particularly in countries like China, Japan, and India. However, market penetration remains lower in regions like Latin America and Africa, where limited awareness and access to supplements are key challenges. Nonetheless, these regions present untapped opportunities for market growth as awareness and economic conditions improve.

Cardiovascular Health Supplements Market- Competitive Landscape:

Key industry participants include established companies like Abbott Laboratories, Amway, Bayer AG, and Herbalife Nutrition, which leverage strong brand recognition, extensive distribution networks, and robust research and development capabilities. These companies are focused on product innovation, often incorporating scientifically-backed ingredients such as omega-3 fatty acids, CoQ10, and plant sterols to differentiate their offerings. Additionally, many players are expanding their product portfolios to include personalized supplements tailored to individual health needs, thereby attracting a broader consumer base. The market also sees significant competition from smaller, specialized companies that cater to niche markets with unique formulations and natural ingredients. Strategic partnerships, mergers, and acquisitions are common as companies seek to enhance their market presence and geographic reach. Despite the intense competition, the growing demand for heart health supplements continues to provide ample opportunities for new entrants and existing players alike.

Recent Developments:

In June 2023, Healthycell launched Heart & Vascular Health, an ultra-absorbable gel supplement aimed at supporting normal cholesterol, triglyceride, and blood pressure levels. It combines plant-based ingredients and vitamins, offering an easy, drug-free heart health solution in a single gel pack.

In July 2023, UK-based Dr. Vegan launched two new supplements: HeartPro for cardiovascular support with plant sterols, and pH Hero for women's vaginal health with probiotics. The launch expands the brand's plant-based offerings to meet growing consumer demand for natural, ethical supplements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Nature's Bounty Co.
  • Herbalife Nutrition Ltd.
  • Amgen Inc.
  • GNC Holdings, Inc.
  • BASF SE
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • DSM Nutritional Products
  • The Nature's Way Products, LLC
  • Nutrilite (Amway)
  • MegaFood (FoodState)
  • Now Foods
  • Solgar Inc.
  • Blackmores Limited
  • Thrive Market
  • Others

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY SUPPLEMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Fiber Supplements
  • Plant Sterols
  • Antioxidants

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Capsules
  • Powders
  • Liquid Supplements
  • Gummies

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Online Retail
  • Health Food Stores
  • Pharmacies
  • Supermarkets
  • Direct Sales

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DEMOGRAPHICS- MARKET ANALYSIS, 2019 - 2032

  • Adults
  • Elderly
  • Children
  • Specific Health Conditions

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiovascular Health Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiovascular Health Supplements Market Snippet by Supplement Type
    • 2.1.2. Cardiovascular Health Supplements Market Snippet by Form
    • 2.1.3. Cardiovascular Health Supplements Market Snippet by Distribution
    • 2.1.4. Cardiovascular Health Supplements Market Snippet by Demographics
    • 2.1.5. Cardiovascular Health Supplements Market Snippet by Country
    • 2.1.6. Cardiovascular Health Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiovascular Health Supplements Key Market Trends

  • 3.1. Cardiovascular Health Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiovascular Health Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiovascular Health Supplements Market Opportunities
  • 3.4. Cardiovascular Health Supplements Market Future Trends

4. Cardiovascular Health Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiovascular Health Supplements Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cardiovascular Health Supplements Market Landscape

  • 6.1. Cardiovascular Health Supplements Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiovascular Health Supplements Market - By Supplement Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Supplement Type, 2023 & 2032 (%)
    • 7.1.2. Omega-3 Fatty Acids
    • 7.1.3. Coenzyme Q10
    • 7.1.4. Fiber Supplements
    • 7.1.5. Plant Sterols
    • 7.1.6. Antioxidants

8. Cardiovascular Health Supplements Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules
    • 8.1.4. Powders
    • 8.1.5. Liquid Supplements
    • 8.1.6. Gummies

9. Cardiovascular Health Supplements Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Online Retail
    • 9.1.3. Health Food Stores
    • 9.1.4. Pharmacies
    • 9.1.5. Supermarkets
    • 9.1.6. Direct Sales

10. Cardiovascular Health Supplements Market - By Demographics

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Demographics, 2023 & 2032 (%)
    • 10.1.2. Adults
    • 10.1.3. Elderly
    • 10.1.4. Children
    • 10.1.5. Specific Health Conditions

11. Cardiovascular Health Supplements Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cardiovascular Health Supplements Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cardiovascular Health Supplements Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cardiovascular Health Supplements Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Cardiovascular Health Supplements Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Cardiovascular Health Supplements Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cardiovascular Health Supplements Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Nature's Bounty Co.
    • 12.2.3. Herbalife Nutrition Ltd.
    • 12.2.4. Amgen Inc.
    • 12.2.5. GNC Holdings, Inc.
    • 12.2.6. BASF SE
    • 12.2.7. Abbott Laboratories
    • 12.2.8. GlaxoSmithKline plc
    • 12.2.9. DSM Nutritional Products
    • 12.2.10. The Nature's Way Products, LLC
    • 12.2.11. Nutrilite (Amway)
    • 12.2.12. MegaFood (FoodState)
    • 12.2.13. Now Foods
    • 12.2.14. Solgar Inc.
    • 12.2.15. Blackmores Limited
    • 12.2.16. Thrive Market
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us